Despite the significant advances in the transfusion medicine field, maintaining an adequate and safe blood supply remains challenging for some areas of the world. Data from the World Health Organization reveal that many developing countries continue to have low rates of blood collections per capita, and many suffer from chronic shortage of blood and components. An effective way to improve access to affordable and quality assured blood and blood products, and their appropriate use is through the establishment of an effective, sustainable and appropriately regulated blood system. At the current time, Saudi Arabia continues to operate in an institution-based model, with a blood collection and processing centre affiliated with almost all individual hospitals. Given the high number of sectors that hospitals belong to, challenges are faced in communication and collaboration among blood centres despite the possibility of being in geographic proximity. Building a national blood system is expected to result in positive outcomes in many aspects, including donor motivation strategies and planning, standardization of policies and processes, and effective utilization of resources and supplies. A hybrid model where motivation efforts, management of financial resources, creation of policies and standards are shared nationally, while blood collection and processing, testing and storage are performed in multiple sites may be the most suitable approach for the country. Steps are being taken towards achieving this goal in the Kingdom.
Professionals, working in the transfusion medicine field, are faced by many challenges on various levels. Data from the World Health Organization (WHO) show that sustaining an adequate and safe blood supply is a challenge faced by many middle and low-income countries [1] . Improvements in this matter require the availability of a reliable national blood system that can satisfy the requirements of the country. In 2017, the WHO published the strategic framework for blood safety and availability (2016) (2017) (2018) (2019) (2020) (2021) (2022) (2023) (2024) (2025) [2] , intended to guide countries in developing and strengthening national blood systems. The strategic framework was endorsed by the WHO Regional Committee for the Eastern Mediterranean in 2016 in resolution EM/RC63/R.6. This review goes over the various models of national blood systems, and the current situation in Saudi Arabia using the 5-element framework suggested by the WHO for building national blood systems [2] . These five elements are as follows:
• Leadership and governance • Coordination and collaboration • Provision of safe blood and blood products • Clinical transfusion in patient management • Quality system management throughout the blood transfusion chain.
Models for national blood systems
National blood systems may exist in various models [3] . A commonly utilized one is development of a national blood supplier. In this model, all steps towards provision of the blood supply are taken by one entity. Canadian Blood Services (CBS)/Hema Quebec (HC) make a good Correspondence: Maha A. Badawi, Department of Hematology, Faculty of Medicine, King Abdulaziz University, P.O. Box 80215, Jeddah 21589, Saudi Arabia E-mail: mbadawi2@kau.edu.sa example of this model, as all blood components collected in Canada are collected by CBS/HC. The hospital-based model is an alternative that exists in a number of countries. In this model, blood collection takes place within hospitals, and entire vein-to-vein transfusion chain is conducted within hospital premises. Such a supplier may operate as an independent entity with distinct regulations and governance, with simply the physical location being in the health care institute. Alternatively, the blood supplier could be an integral part of the hospital transfusion medicine laboratory. Legal considerations must be taken into account, when planning and developing hospital blood banks, to avoid lack of clarity in roles and responsibilities, especially in relation to product liability (the responsibility of the supplier or manufacturer), and the need to protect patient rights, a significant responsibility of the health care institute. Ideally the regulatory authority is independent to both.
In Saudi Arabia, the majority of blood collection and manufacturing activities take place in hospital-based blood centres [1, 4, 5] . Hospitals in Saudi Arabia may belong to one of many sectors, including the Ministry of Health (MOH), national guard, military, universities, in addition to the private sector. This situation resulted in the current hospital-based model for blood banking. A small number of regional blood centres that are operated by MOH are established and are not affiliated with specific hospitals, but are closely related to regional reference laboratories, also run by MOH. These regional blood centres augment the blood supply in small sized health care establishments that belong to MOH.
Leadership and governance
The presence of a national blood policy is encouraged by the WHO as it defines governance of activities related to blood collection and transfusion processes. An effective national blood policy ensures proper utilization of this finite resource for the safety of blood donors, patients receiving transfusions, and staff working in the field [6, 7] .
A national transfusion policy has been in place in Saudi Arabia for many years. All blood collection centres must follow regulations of the General Directorate of Laboratories and Blood Banks, a division under MOH. Under the umbrella of the General Directorate, the National Committee for Laboratories and Blood Banks Quality Assurance and the Advisory Committee are responsible for developing the national blood policy, and providing advice on uprising matters related to transfusion or stem cell transplantation.
In 2013, the Saudi Central Board for Accreditation of Healthcare Institutions (CBAHI) emerged as the official agency to grant accreditation certificates to all health care facilities, blood banks and laboratories operating in the Kingdom. Accreditation certificates are now a prerequisite for renewal of operating licenses.
CBAHI standards cover recommended practices of both the blood supplier (manufacturer) and the health care institute responsibility in relation to blood transfusion in a document titled National Standards for Clinical Laboratories and Blood Banks. Similar standards are also found within the laboratory section in CBAHI National Hospital Standards [8] . This illustrates a common theme found in the Kingdom: lack of clear boundaries between roles of the blood supplier and hospital transfusion medicine laboratory, and hesitation in separation of both from other laboratories despite the major difference in the nature and scope of provided services.
Coordination and collaboration
In the absence of a single body representing a national blood supplier in Saudi Arabia, coordination and collaboration is major area for improvement. This is illustrated through the following:
Donor selection
Despite that CBAHI standards apply to all hospital and blood collection facilities, variations may occasionally exist in donor selection criteria, exposing the population to different and potentially confusing messages. Improved trust in the blood system, and increased commitment to donate may be an advantage to uniform donor motivation and selection procedure.
Management of deferred donors
Maintaining records of all deferred donors, especially those with positive testing for transfusion transmissible infections (TTI), is an important requirement to enhance safety of the blood supply. This is easily achieved when all collections are performed by the National Blood Supplier. In the absence of such entity, electronic records of deferred donors should be shared confidentially among collection centres using unique identification numbers of donors. This is expected to enhance safety of the blood supply on a national level.
Coordination of selection, procurement and maintenance of equipment, devices and consumables
Economies of scale suggest that the average cost of production is decreased with increase in production (to a limit) [9] . Standardization of blood collection bags and other material used in blood processing and collection may be achieved even in the absence of a single blood collection entity. This was achieved by the European Blood Alliance and proved to result in significant cost savings [10] .
Inventory management
Different health care facilities may serve different categories of patients with different needs. Centres located in areas with high prevalence of haemoglobinopathies have high demand of red cells, while cancer centres have an additional need for platelets. A product that may outdate at one site may be in needed in another. Established agreements facilitate collaboration among various centres within geographic proximity, but sharing inventory data among more centres and development of a program for redistribution of blood products is a significant advantage to the development of a national blood service. Development of a centralized national blood information management system in Saudi Arabia is ongoing.
Provision of safe blood and blood products
More work needs to be done in this section of the transfusion chain in Saudi Arabia, as availability of blood, remains an issue in the Kingdom. The Kingdom is categorized by the World Bank among high-income counties [11] . The rates of whole blood collection (13Á8 per 1000 population), however, are aligned with those of upper middle-income countries [12] . Apheresis procedures are also performed, mostly for platelets collections. In 2013, 415 000 whole blood donations were collected, while 12 550 apheresis procedures were performed. These low numbers are also typically seen in medium-income, rather than high-income countries [1] . It is expected that visitors of the Muslim holy sites may be an excess of 30 million per year by 2030. Such visitors are typically of older age and some of them require medical care. Health care facilities must be ready to handle the expected increase in demand.
In addition to the necessary increase in donor numbers, motivating the safest category of donors is also essential. In alignment with the WHO strategic framework for 2025, countries must strive to achieve 100% voluntary donation [2] . As a country, around 40% of donors in the Kingdom belong to this category [12] , while the remaining 60% are comprised of donors from families and friends of patients, requested by hospitals to donate to replace what their patient may utilize [4] . It may be quite effective to consolidate donor motivation efforts on a national level, even if a single national blood system is still under development. Unlike many steps of the process of blood collections and manufacturing, donor motivation requires an additional set of competencies in marketing, donor management and effective utilization of social media. Consolidation of such efforts will improve the overall donation rates, and will most affect small collection centres that might experience challenges in hiring skilful personnel to handle donor motivation. In the absence of such national efforts, every collection centre must rely on its own efforts to spread the message of blood donation. When the flow of volunteer donors is not adequate to fulfil demand, collection centres may need to request family replacement as described above [4] . Paid donations may also still exist in some areas of the world, but that is not permitted according to the Saudi National Blood Policy, in compliance with WHO guidance.
In order to maintain safety of the blood supply in Saudi Arabia, collections are screened for the following TTI, as required by both MOH and CBAHI: • Syphilis: antibody testing • Malaria.
This also conforms to mandated tests on donated blood suggested by WHO (HIV 1&2, HBV, HCV and syphilis) and European Union. [2, 13] .
After successful standardization of testing, consolidation of testing centres must urgently be considered. Drastic savings of costs in reagents and reduced turnaround time are expected [14] . In addition, this is expected to have a positive effect on personnel competency and expertise. Given the extreme temperatures that may be encountered in Saudi Arabia, especially during the summer months, testing centres may need to be established in each major city with transportation of samples under controlled conditions.
The majority of physicians certified in transfusion medicine are certified from North America, Europe and Australia. A postgraduate training program have recently been approved by the Saudi Commission for Health Specialties (the body in charge of approving and supervising postgraduate training programs for health care professionals in Saudi Arabia) for laboratory technologists [15] , a major step in increasing the number of qualified personnel working in the field.
Clinical transfusion in patient management
Implementation of CBAHI standards in all hospitals is expected to result in improved transfusion management, as such standards mandate creation of hospital transfusion committees to facilitate collaboration with physicians from different fields in regards to proper transfusion utilization. In the same time, institutions are expected to comply with the same standards in regards to proper pre transfusion compatibility testing.
The Saudi Society of Transfusion Medicine (SSTM), created in 2010, in addition to other educational institutions and professional societies, provide continuous professional development opportunities to health care professionals from all fields to improve transfusion practices and patient blood management in the Kingdom. SSTM is viewed by many professionals as a suitable entity to develop and disseminate national transfusion guidelines, which is still lacking.
Quality system management throughout the blood transfusion chain
The healthcare sector in Saudi Arabia has shown strong commitment to establish appropriate quality systems, and this is illustrated by the growing number of health care institutions of all sizes achieving national and international accreditation status. Given that licensure of any healthcare institutions will be linked to accomplishing CBAHI accreditation, achieving the minimum requirements for a quality system will be necessary for all institutions.
One important future step that is expected to improve outcomes is development of a national haemovigilance program. The Saudi Food and Drug Authority is currently in charge of pharmacovigilance in the Kingdom, and may be a suitable candidate for development of the haemovigilance program on a national level. However, in order to track and monitor data on a national level, competent and comprehensive quality management systems with unified definitions and coding are essential.
Countries that lack national standards for transfusion medicine and blood banking may consider utilization of the Fundamental Standards for Blood Collection and Transfusion, published this year by AABB [16] . These standards are not linked to a specific accreditation program, but were created to describe minimum requirements for a qualityoriented approach to blood collection and transfusion.
Conclusion
Blood suppliers in the Kingdom of Saudi Arabia continue to operate in a hospital-based model. Establishment of a national blood supplier is expected to result in many improvements in the transfusion scene. Until that is achieved, consolidation of various steps of the transfusion process among centres will likely result in cost savings and improve quality and safety of the process. Countries planning to improve the transfusion medicine field are urged to utilize the recommendations of the strategic framework provided by the WHO, the stepwise approach to building a blood system [17] , also provided by WHO, in addition to development of national standards for blood banks and transfusion medicine laboratories, or adoption of another set of standards from a recognized entity in the field.
